FCPA Docket: Bio-Rad’s GC whistleblower saga goes on

In today’s news round-up, a California pharmaceutical company is taking an unfair dismissal case to an appeals court, and the lower legislative body of Congress votes to reform the SEC’s whistleblower awards programme.

Unlock unlimited access to all Global Investigations Review content